drugset / Trial / NCT02401139

Ketamine Trial for the Treatment of Depression

NCT02401139

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.

Timeline

Start
2015-03
Primary completion
2015-07
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule